IBDEI1MD ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1001,0)
 ;;=HERNIA^10^78
 ;;^UTILITY(U,$J,358.4,1002,0)
 ;;=GENITOURINARY^6^78
 ;;^UTILITY(U,$J,358.4,1003,0)
 ;;=SKIN^22^78
 ;;^UTILITY(U,$J,358.4,1004,0)
 ;;=ENT^4^78
 ;;^UTILITY(U,$J,358.4,1005,0)
 ;;=RHEUMATOLOGY/ORTHO^20^78
 ;;^UTILITY(U,$J,358.4,1006,0)
 ;;=RESPIRATORY^19^78
 ;;^UTILITY(U,$J,358.4,1007,0)
 ;;=SIGNS/SYMPTOMS/HX OF^21^78
 ;;^UTILITY(U,$J,358.4,1008,0)
 ;;=VASCULAR^24^78
 ;;^UTILITY(U,$J,358.4,1009,0)
 ;;=ANTICOAGULATION^2^78
 ;;^UTILITY(U,$J,358.4,1010,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^78
 ;;^UTILITY(U,$J,358.4,1011,0)
 ;;=ALLERGY/ASTHMA^1^78
 ;;^UTILITY(U,$J,358.4,1012,0)
 ;;=EYES^5^78
 ;;^UTILITY(U,$J,358.4,1013,0)
 ;;=HEADACHES^8^78
 ;;^UTILITY(U,$J,358.4,1014,0)
 ;;=IMMUNOLOGY^11^78
 ;;^UTILITY(U,$J,358.4,1015,0)
 ;;=NICOTINE DEPENDENCE^16^78
 ;;^UTILITY(U,$J,358.4,1016,0)
 ;;=PERSONAL HX/STATUS^18^78
 ;;^UTILITY(U,$J,358.4,1017,0)
 ;;=COMMON DIAGNOSES^1^79
 ;;^UTILITY(U,$J,358.4,1018,0)
 ;;=BODY MASS INDEX^3^79
 ;;^UTILITY(U,$J,358.4,1019,0)
 ;;=OBESITY^5^79
 ;;^UTILITY(U,$J,358.4,1020,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^6^79
 ;;^UTILITY(U,$J,358.4,1021,0)
 ;;=ANTICOAGULATION^2^79
 ;;^UTILITY(U,$J,358.4,1022,0)
 ;;=EYE^4^79
 ;;^UTILITY(U,$J,358.4,1023,0)
 ;;=MD/NP/PA ^1^80
 ;;^UTILITY(U,$J,358.4,1024,0)
 ;;=RN/LPN/SW/OTH HC PROF^2^80
 ;;^UTILITY(U,$J,358.4,1025,0)
 ;;=NEW PATIENT^2^81
 ;;^UTILITY(U,$J,358.4,1026,0)
 ;;=ESTABLISHED PATIENT^1^81
 ;;^UTILITY(U,$J,358.4,1027,0)
 ;;=CONSULTATIONS^3^81
 ;;^UTILITY(U,$J,358.4,1028,0)
 ;;=POST-OP F/U VISIT^5^81
 ;;^UTILITY(U,$J,358.4,1029,0)
 ;;=PREVENTIVE MED-EST PT^6^81
 ;;^UTILITY(U,$J,358.4,1030,0)
 ;;=PREVENTIVE MED-NEW PT^7^81
 ;;^UTILITY(U,$J,358.4,1031,0)
 ;;=GENITOURINARY & RENAL^19^82
 ;;^UTILITY(U,$J,358.4,1032,0)
 ;;=GYNECOLOGICAL/BREAST^20^82
 ;;^UTILITY(U,$J,358.4,1033,0)
 ;;=CARDIO/VASCULAR^14^82
 ;;^UTILITY(U,$J,358.4,1034,0)
 ;;=ENDOCRINE/METABOLIC/NUTRITION^16^82
 ;;^UTILITY(U,$J,358.4,1035,0)
 ;;=EYES/EARS/NOSE^17^82
 ;;^UTILITY(U,$J,358.4,1036,0)
 ;;=GASTROINTESTINAL^18^82
 ;;^UTILITY(U,$J,358.4,1037,0)
 ;;=MUSCULOSKELETAL^23^82
 ;;^UTILITY(U,$J,358.4,1038,0)
 ;;=NEUROLOGY^24^82
 ;;^UTILITY(U,$J,358.4,1039,0)
 ;;=PULMONARY^25^82
 ;;^UTILITY(U,$J,358.4,1040,0)
 ;;=PSYCHIATRIC^26^82
 ;;^UTILITY(U,$J,358.4,1041,0)
 ;;=SKIN^27^82
 ;;^UTILITY(U,$J,358.4,1042,0)
 ;;=IMMUNIZATIONS^21^82
 ;;^UTILITY(U,$J,358.4,1043,0)
 ;;=MISCELLANEOUS^22^82
 ;;^UTILITY(U,$J,358.4,1044,0)
 ;;=PC COMMON DIAGNOSES^1^82
 ;;^UTILITY(U,$J,358.4,1045,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^2^82
 ;;^UTILITY(U,$J,358.4,1046,0)
 ;;=ACSC ANGINA^3^82
 ;;^UTILITY(U,$J,358.4,1047,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^4^82
 ;;^UTILITY(U,$J,358.4,1048,0)
 ;;=ACSC CHF^5^82
 ;;^UTILITY(U,$J,358.4,1049,0)
 ;;=ACSC DEHYDRATION^6^82
 ;;^UTILITY(U,$J,358.4,1050,0)
 ;;=ACSC DIABETES TYPE 1^7^82
 ;;^UTILITY(U,$J,358.4,1051,0)
 ;;=ACSC DIABETES TYPE 2^8^82
 ;;^UTILITY(U,$J,358.4,1052,0)
 ;;=ACSC HYPERTENSION^9^82
 ;;^UTILITY(U,$J,358.4,1053,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^10^82
 ;;^UTILITY(U,$J,358.4,1054,0)
 ;;=ACSC PNEUMONIA^11^82
 ;;^UTILITY(U,$J,358.4,1055,0)
 ;;=ACSC UTI^12^82
 ;;^UTILITY(U,$J,358.4,1056,0)
 ;;=ACSC VIRAL ENTERITIS^13^82
 ;;^UTILITY(U,$J,358.4,1057,0)
 ;;=COVID-19^15^82
 ;;^UTILITY(U,$J,358.4,1058,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^28^82
 ;;^UTILITY(U,$J,358.4,1059,0)
 ;;=GYN PROCEDURES^1^83
 ;;^UTILITY(U,$J,358.4,1060,0)
 ;;=INJECTIONS^11^83
